Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IRF9 Antikörper (AA 44-180) (HRP)

IRF9 Reaktivität: Human ELISA Wirt: Kaninchen Polyclonal HRP
Produktnummer ABIN7156640
  • Target Alle IRF9 Antikörper anzeigen
    IRF9 (Interferon Regulatory Factor 9 (IRF9))
    Bindungsspezifität
    • 15
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 44-180
    Reaktivität
    • 48
    • 16
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 42
    • 7
    • 1
    Kaninchen
    Klonalität
    • 44
    • 5
    Polyklonal
    Konjugat
    • 26
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IRF9 Antikörper ist konjugiert mit HRP
    Applikation
    • 37
    • 14
    • 13
    • 13
    • 10
    • 9
    • 8
    • 3
    • 3
    • 2
    • 2
    ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Interferon regulatory factor 9 protein (44-180AA)
    Isotyp
    IgG
    Top Product
    Discover our top product IRF9 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    IRF9 (Interferon Regulatory Factor 9 (IRF9))
    Andere Bezeichnung
    IRF9 (IRF9 Produkte)
    Synonyme
    IRF-9 antikoerper, ISGF3 antikoerper, ISGF3G antikoerper, p48 antikoerper, zgc:92097 antikoerper, Irf-9 antikoerper, Isgf3g antikoerper, interferon regulatory factor 9 antikoerper, IRF9 antikoerper, irf9 antikoerper, Irf9 antikoerper
    Hintergrund

    Background: Transcription factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G associates with the phosphorylated STAT1:STAT2 dimer to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.

    Aliases: IFN alpha responsive transcription factor subunit antibody, IFN-alpha-responsive transcription factor subunit antibody, Interferon regulatory factor 9 antibody, interferon stimulated transcription factor 3 antibody, Interferon-stimulated gene factor 3 gamma antibody, interferon-stimulated transcription factor 3, gamma 48 kDa antibody, IRF 9 antibody, IRF-9 antibody, Irf9 antibody, IRF9_HUMAN antibody, ISGF 3 gamma antibody, ISGF-3 gamma antibody, ISGF3 antibody, ISGF3 p48 subunit antibody, ISGF3G antibody, OTTHUMP00000164692 antibody, OTTHUMP00000164693 antibody, p48 antibody, Transcriptional regulator ISGF3 subunit gamma antibody

    UniProt
    Q00978
    Pathways
    JAK-STAT Signalweg, Interferon-gamma Pathway, Hepatitis C
Sie sind hier: